Neuronal dopamine transporter activity, density and methamphetamine inhibition are differentially altered in the nucleus accumbens and striatum with no changes in glycosylation in rats behaviorally sensitized to methamphetamine

Synapse

Volumn 62, Issue 10, 2008, Pages 736-745

  Bjorklund, Nicole L ^a   Sorg, Barbara A ^a   Schenk, James O ^a  

^a WASHINGTON STATE UNIVERSITY   (United States)

Author keywords

Drugs of abuse; Glycosylation; Neuroadaptation; Rotating disk electrode voltammetry

Indexed keywords

ALPHA MANNOSIDASE; DOPAMINE TRANSPORTER; GLYCOPEPTIDASE; GLYCOSIDASE; METHAMPHETAMINE; SIALIDASE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINERGIC SYSTEM; GLYCOSYLATION; IC 50; KINETICS; MALE; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; RAT; SENSITIZATION; WESTERN BLOTTING;

ANIMALS; CORPUS STRIATUM; DOPAMINE; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; DOSE-RESPONSE RELATIONSHIP, DRUG; GLYCOSYLATION; MALE; METHAMPHETAMINE; MOTOR ACTIVITY; NEURONS; NUCLEUS ACCUMBENS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 50249124862     PISSN: 08874476     EISSN: 10982396     Source Type: Journal    
DOI: 10.1002/syn.20528     Document Type: Article

References (54)

1. Belcher AM, O'Dell SJ, Marshall JF. 2006. A sensitizing regimen of methamphetamine causes impairments in a novelty preference task of object recognition. Behav Brain Res 170:167-172.
2. Bennett BA, Hollingsworth CK, Martin RS, Harp JJ. 1998. Methamphetamine-induced alterations in dopamine transporter function. Brain Res 782:219-227.
3. Brady AM, Glick SD, O'Donnell P. 2005. Selective disruption of nucleus accumbens gating mechanisms in rats behaviorally sensitized to methamphetamine. J Neurosci 25:6687-6695.
4. Braza-Boïls A, Tomás M, Marín MP, Megías L, Sancho-Tello M, Fornas E, Renau-Piqueras J. 2006. Glycosylation is altered by ethanol in rat hippocampal cultured neurons. Alcohol Alcohol 41:494-504.
5. Delfs J, Schreiber L, Kelley A. 1990. Microinjection of cocaine into the nucleus accumbens eleicits locomotor activation in the rat. J Neurosci 10:303-310.
6. Fleckenstein AE, Metzger RR, Gibb JW, Hanson GR. 1997. A rapid and reversible change in dopamine transporters induced by methamphetamine. Eur J Pharmacol 323:R9-R10.
7. Freed C, Revay R, Vaughan RA, Kriek E, Grant S, Uhl GR, Kuhar MJ. 1995. Dopamine transporter immunoreactivity in rat brain. J Comp Neurol 359:340-349.
8. Frey K, Kilbourn M, Robinson T. 1997. Reduced striatal vesicular monoamine transporters after neurotoxic but not after behaviorally-sensitizing doses of methamphetamine. Eur J Pharmacol 334: 273-279.
9. Fumagalli F, Gainetdinov RR, Valenzano KJ, Caron MG. 1998. Role of dopamine transporter in methamphetamine-induced neurotoxicity: Evidence from mice lacking the transporter. J Neurosci 18: 4861-4869.
10. Genova L, Berke J, Hyman SE. 1997. Molecular adaptations to psychostimulants in striatal neurons: Toward a pathophysiology of addiction. Neurobiol Dis 4:239-246.
11. Gulley JM, Zahniser NR. 2003. Rapid regulation of dopamine transporter function by substrates, blockers and presynaptic receptor ligands. Eur J Pharmacol 479:139-152.
12. Havlicek LL, Crain RD. 1988. Practical statistics for the physical sciences. Washington, DC: American Chemical Society.
13. Itzhak Y, Martin JL, Ali SF. 2002. Methamphetamine-induced dopaminergic neurotoxicity in mice. Long-lasting sensitization to the locomotor stimulation and desensitization to the rewarding effects of methamphetamine. Prog Neuropsychopharmacol Biol Psychiatry 26:1177-1183.
14. Jones SR, Joseph JD, Barak LS, Caron MG, Wightman RM. 1999. Dopamine neuronal transport kinetics and effects of amphetamine. J Neurochem 73:2406-2414.
15. Kalivas PW, Duffy P, DuMars LA, Skinner C. 1988. Behavioral and neurochemical effects of acute and daily cocaine administration in rats. J Pharmacol Exp Ther 245:485-492.
16. Kazahaya Y, Akimoto K, Otsuki S. 1989. Subchronic methamphetamine treatment enhances methamphetamine- or cocaine-induced dopamine efflux in vivo. Biol Psychiatry 25:903-912.
17. Kelly P, Seviour P, Iverson S. 1975. Amphetamine and apomorphine responses in the rat following 6-OHDA lesions of the nucleus accumbens septi and corpus striatum. Brain Res 94:507-522.
18. Kimmel H, Carroll FI, Kuhar MJ. 2003. Withdrawal from repeated cocaine alters dopamine transporter protein turnover in the rat striatum. J Pharmacol Exp Ther 304:15-21.
19. Kokoshka JM, Vaughan RA, Hanson GR, Fleckenstein AE. 1998. Nature of methamphetamine-induced rapid and reversible changes in dopamine transporters. Eur J Pharmacol 361:269-275.
20. Letchworth SR, Nader MA, Smith HR, Friedman DP, Porrino LJ. 2001. Progression of changes in dopamine transporter binding site density as a result of cocaine self-administration in rhesus monkeys. J Neurosci 21:2799-2807.
21. Lew R, Grigoriadis D, Wilson A, Boja JW, Simantov R, Kuhar MJ. 1991a. Dopamine transporter: Deglycosylation with exo- and endoglycosidases. Brain Res 539:239-246.
22. Lew R, Vaughan R, Simantov R, Wilson A, Kuhar MJ. 1991b. Dopamine transporters in the nucleus accumbens and the striatum have different apparent molecular weights. Synapse 8:152-153.
23. Lew R, Patel A, Vaughan RA, Wilson A, Kuhar MJ. 1992. Microheterogeneity of dopamine transporters in rat striatum and nucleus accumbens. Brain Res 584:266-271.
24. McBride WJ, Murphy JM, Ikemoto S. 1999. Localization of brain reinforcement mechanisms: Intracranial self-administration and intracranial place-conditioning studies. Behav Brain Res 101:129-152.
25. McElvain JS, Schenk JO. 1992. A multisubstrate mechanism of striatal dopamine uptake and its inhibition by cocaine. Biochem Pharmacol 43:2189-2199.
26. Meiergerd SM, Schenk JO. 1994. Striatal transporter for dopamine: Catechol structure-activity studies and susceptibility to chemical modifications. J Neurochem 62:998-1008.
27. Mittleman G, Jones G, Robbins T. 1991. Sensitization of amphetamine-strereotypy reduces plasma corticosterone: Implications for stereotypy as a coping response. Behav Neural Biol 56:170-182.
28. Nakayama M, Koyama T, Yamashita I. 1993. Long-lasting decrease in dopamine uptake sites following repeated administration of methamphetamine in the rat striatum. Brain Res 601:209-212.
29. Natarajan SK, Ramamoorthy P, Thomas S, Basivireddy J, Kang G, Ramachandran A, Pulimood AB, Balasubramanian KA. 2006. Intestinal mucosal alterations in rats with carbon tetrachloride-induced cirrhosis: Changes in glycosylation and luminal bacteria. Hepatology (Hoboken, NJ, United States) 43:837-846.
30. Nestler EJ. 2001. Molecular basis of long-term plasticity underlying addiction. Nat Rev Neurosci 2:119-128.
31. Patel AP, Cerruti C, Vaughan RA, Kuhar MJ. 1994. Developmentally regulated glycosylation of dopamine transporter. Brain Res Dev Brain Res 83:53-58.
32. Pierce RC, Kalivas PW. 1997. A circuitry model of the expression of behavioral sensitization to amphetamine-like psychostimulants. Brain Res Rev 25:192-216.
33. Porrino LJ, Lyons D, Smith HR, Daunais JB, Nader MA. 2004. Cocaine self-administration produces a progressive involvement of limbic, association, and sensorimotor striatal domains. J Neurosci 24:3554-3562.
34. Povlock SL, Meiergerd SM, Schenk JO. 1996. Kinetic mechanisms of the dopamine transporter: A comparison with other biogenic amine transporters. In: Stone TW, editor. CNS Neurotransmitters and Neuromodulators: Dopamine. Boca Raton, Florida: CRC Press. p 21-39.
35. Povlock SL, Schenk JO. 1997. A multisubstrate kinetic mechanism of dopamine transport in the nucleus accumbens and its inhibition by cocaine. J Neurochem 69:1093-1105.
36. Raiteri M, Bertollini A, Angelini F, Levi G. 1975. d-Amphetamine as a releaser or reuptake inhibitor of biogenic amines in synaptosomes. Eur J Pharmacol 34:189-195.
37. Raiteri M, Del Carmine R, Bertollini A, Levi G. 1977. Effect of sympathomimetic amines on the synaptosomal transport of noradrenaline, dopamine and 5-hydroxytryptamine. Eur J Pharmacol 41: 133-143.
38. Robinson TE, Becker JB. 1982. Behavioral sensitization is accompanied by an enhancement in amphetamine-stimulated dopamine release from striatal tissue in vitro. Eur J Pharmacol 85:253-254.
39. Robinson TE, Berridge KC. 1993. The neural basis of drug craving: An incentive-sensitization theory of addiction. Brain Res Rev 18: 247-291.
40. Sáez-Valero J, Small DH. 2001. Altered glycosylation of cerebrospinal fluid butyrylcholinesterase in Alzheimer's disease. Brain Res 889:247-250.
41. Sleipness EP, Sorg BA, Jansen HT. 2007. Diurnal differences in dopamine transporter and tyrosine hydroxylase levels in rat brain: Dependence on the suprachiasmatic nucleus. Brain Res 1129:34-42.
42. Stefanski R, Ladenheim B, Lee SH, Cadet JL, Goldberg SR. 1999. Neuroadaptations in the dopaminergic system after active self-administration but not after passive administration of methamphetamine. Eur J Pharmacol 371:123-135.
43. Stefanski R, Lee S-H, Yasar S, Cadet JL, Goldberg SR. 2002. Lack of persistent changes in the dopaminergic system of rats withdrawn from methamphetamine self-administration. Eur J Pharmacol 439:59-68.
44. Vanderschuren LJMJ, Everitt BJ. 2005. Behavioral and neural mechanisms of compulsive drug seeking. Eur J Pharmacol 526: 77-88.
45. Vaughan RA, Brown VL, McCoy MT, Kuhar MJ. 1996. Species- and brain region-specific dopamine transporters: Immunological and glycosylation characteristics. J Neurochem 66:2146-2152.
46. Volz TJ, Fleckenstein AE, Hanson GR. 2007. Methamphetamine-induced alterations in monoamine transport: Implications for neurotoxicity, neuroprotection and treatment. Addiction 102:44-48.
47. Volz TJ, Kim M, Schenk JO. 2004. Covalent and noncovalent chemical modifications of arginine residues decrease dopamine transporter activity. Synapse 52:272-282.
48. Wayment H, Meiergerd SM, Schenk JO. 1998. Relationships between the catechol substrate binding site and amphetamine, cocaine, and mazindol binding sites in a kinetic model of the striatal transporter of dopamine in vitro. J Neurochem 70:1941-1949.
49. Wayment HK, Deutsch H, Schweri MM, Schenk JO. 1999. Effects of methylphenidate analogs on phenethylamine substrates for the striatal dopamine transporter: Potential as amphetamine antagonists? J Neurochem 72:1266-1274.
50. White FJ, Kalivas PW. 1998. Neuroadaptations involved in amphetamine and cocaine addiction. Drug Alcohol Depend 51:141-153.
51. Wise RA. 1998. Drug-activation of brain reward pathways. Drug Alcohol Depend 51:13-22.
52. Yamada S, Kojima H, Yokoo H, Tsutsumi T, Takamuki K, Anraku S, Nishi S, Inanaga K. 1988. Enhancement of dopamine release from striatal slices of rats that were subchronically treated with methamphetamine. Biol Psychiatry 24:399-408.
53. Zahniser NR, Sorkin A. 2004. Rapid regulation of the dopamine transporter: Role in stimulant addiction? Neuropharmacology 47: 80-91.
54. Zalewska M, Erecinska M. 1987. Involvement of sialic acid in high-affinity uptake of dopamine by synaptosomes from rat brain. Neurosci Lett 82:107-112.